MORBIDITY WITH MALIGNANT NEOPLASMS OF THE LIVER AND INTRAHEPATIC BILE DUCTS OF THE POPULATION OF THE SVERDLOVSK REGION (FIFTEEN-YEAR FOLLOW-UP)
DOI: 10.22138/2500-0918-2025-22-1-92-101
V.V. Petkau¹,², E.A. Kiselev¹,²,
O.U. Aleksandrova³, N.E. Krasilnikova¹
¹State Autonomous Healthcare Institution “Sverdlovsk Regional Oncology Dispensary”, Yekaterinburg, Russian Federation;
²Ural State Medical University, Yekaterinburg, Russian Federation;
³Research and Education, Federal State Budgetary Institution “N.A. Semashko National Research Institute of Public Health”, Moscow, Russian Federation
Abstract. Aim. Assess trends in the prevalence of primary malignant liver and intrahepatic bile duct tumours among the population of the Sverdlovsk region for the past fifteen years. Materials and Methods: Data from the Sverdlovsk Regional Registry and the information base of the Regional Oncological System (ONCOR) were used. Data for the Russian Federation and the Ural Federal District are obtained from a publicly available source, the Malignant Neoplasms in Russia books for 2007-2022. Statistical and analytical methods were used. Conclusions: As a result of a fifteen-year observation, it was established that in the Sverdlovsk region as a whole, the incidence of primary malignant tumors of the liver and intrahepatic bile ducts had a negative trend in the form of an increase in the standardized indicator. In addition, in the studied region, an annual excess of the standardized indicator compared to the Russian average values was recorded.
Keywords: malignant neoplasms of the liver and intrahepatic ducts, standardized incidence rate
There is no conflict of interest.
Contact details of the corresponding author:
Vladislav V. Petkau
vpetkau@yandex.ru
Received: 29.07.2024
For citation: Petkau V.V., Kiselev E.A., Aleksandrova O.U., Krasilnikova N.E. Morbidity with malignant neoplasms of the liver and intrahepatic bile ducts of the population of the sverdlovsk region (fifteen-year follow-up). [Online] Vestn. Ural. Med. Akad. Nauki. = Journal of Ural Medical Academic Science. 2025, Vol. 22, no. 1, pp. 92–101. DOI: 10.22138/2500-0918-2025-22-1-92-101 (In Russ)
REFERENCES
1. Samant H, Amiri HS, Zibari GB. Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J Gastrointest Oncol. 2021 Jul;12(Suppl 2): S361-S373. doi: 10.21037/jgo.2020.02.08. PMID: 34422400; PMCID: PMC8343080.
2. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)32605-8. PMID: 27733281; PMCID: PMC5388903.
3. Merabishvili V.M., Bagnenko S.S., Balakhnin P.V., Busko E.A. The state of oncological care in Russia: liver cancer — (C22). Age features of the observed and relative one-year and five-year survival of patients. (clinical and population study). Part 2 // Pharmacy formulas. — 2024. — Vol. 6, No. 2. — P. 18-32. — DOI 10.17816/phf631132. — EDN WNDNIC.
4. Global Burden of Disease Liver Cancer Collaboration; Akinyemiju T, Abera S, Ahmed M et al. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol. 2017 Dec 1;3(12):1683-1691. doi: 10.1001/jamaoncol.2017.3055. PMID: 28983565; PMCID: PMC5824275.
5. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. doi: 10.3322/caac.21609. PMID: 30207593.
6. Kaprin A.D., Starinsky V.V., Shakhzadova A.O., Lisichnikova I.V. Malignant neoplasms in Russia in 2022 (morbidity and mortality) — M.: P.A. Herzen Moscow Oncology Research Institute — branch of the Federal State Budgetary Institution «NMITs Radiology» of the Ministry of Health of the Russian Federation, — 2023. — 275 p. ISBN 978-5-85502-290-2
7. Health care in Russia. 2023: Statistical Compendium/Rosstat – М., 2023. – 179 p.
8. Gan T, Bambrick H, Tong S, Hu W. Air pollution and liver cancer: A systematic review. J Environ Sci (China). 2023 Apr;126:817-826. doi: 10.1016/j.jes.2022.05.037. Epub 2022 Jun 2. PMID: 36503807.
9. Kulik L, El-Serag HB. Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology. 2019 Jan;156(2):477-491.e1. doi: 10.1053/j.gastro.2018.08.065. Epub 2018 Oct 24. PMID: 30367835; PMCID: PMC6340716.
10. Thylur RP, Roy SK, Shrivastava A, LaVeist TA, Shankar S, Srivastava RK. Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma. JGH Open. 2020 Apr 15;4(3):351-359. doi: 10.1002/jgh3.12336. PMID: 32514436; PMCID: PMC7273694.
11. Boora S, Sharma V, Kaushik S, Bhupatiraju AV, Singh S, Kaushik S. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem. Braz J Microbiol. 2023 Jun;54(2):679-689. doi: 10.1007/s42770-023-00970-y. Epub 2023 Apr 14. PMID: 37059940; PMCID: PMC10235410.
12. Milosevic I, Todorovic N, Filipovic A, Simic J, Markovic M, Stevanovic O, Malinic J, Katanic N, Mitrovic N, Nikolic N. HCV and HCC Tango-Deciphering the Intricate Dance of Disease: A Review Article. Int J Mol Sci. 2023 Nov 7;24(22):16048. doi: 10.3390/ijms242216048. PMID: 38003240; PMCID: PMC10671156.
13. Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol. 2023 Jan;20(1):37-49. doi: 10.1038/s41575-022-00688-6. Epub 2022 Oct 18. PMID: 36258033; PMCID: PMC9579565.
14. Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023 Dec;20(12):864-884. doi: 10.1038/s41571-023-00825-3. Epub 2023 Oct 26. PMID: 37884736.
15. Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH, Chow PK, Ngeow J. Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology. 2023 Apr;164(5):766-782. doi: 10.1053/j.gastro.2023.01.033. Epub 2023 Feb 2. PMID: 36738977.
16. Larina V.N., Vartanyan E.A., Zagorodskaya I.V. Analysis of the structure of mortality from malignant neoplasms in Moscow in 2019, 2020, 2021. // Oncology. P.A. Herzen Journal. – 2023, Т.12, №4, p. 35 – 41.
Authors
Vladislav V. Petkau
State Autonomous Healthcare Institution “Sverdlovsk Regional Oncology Dispensary”
Candidate of Medical Sciences, Deputy Chief Physician for Drug Therapy
Yekaterinburg, Russian Federation
vpetkau@yandex.ru
ORCID ID 0000-0002-0342-4007
ELIBRARY SPIN-код: 6811-8136
AuthorID: 763872
Evgeniy A. Kiselev
State Autonomous Healthcare Institution “Sverdlovsk Regional Oncology Dispensary”
Candidate of Medical Sciences, Deputy Chief Physician for Medical Work
evgkiseliov@yandex.ru
Yekaterinburg, Russian Federation
ORCID ID 0009-0003-2043-7955
ELIBRARY SPIN-код: 4052-4783.
AuthorID: 820717
Oksana Y. Aleksandrova
Federal State Budgetary Institution “N.A. Semashko National Research Institute of Public Health”
PhD, Deputy Director for Research and Education
Moscow, Russian Federation
aou18@mail.ru
ORCID 0000-0002-7246-4109
ELIBRARY SPIN-код: 6540-7375
AuthorID: 596298
Natalia E. Krasilnikova
State Autonomous Healthcare Institution “Sverdlovsk Regional Oncology Dispensary”
Doctor Resident
Nkrasilnikova98@mail.ru
Yekaterinburg, Russian Federation